Osimertinib - HY-15772
Nur noch %1 verfügbar
Catalog #
HY-15772
Ab
62,00 €
Osimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-15772/Osimertinib-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-Kinase/protease |
| Alternative Names | AZD-9291; Mereletinib |
| CAS | 1421373-65-0 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 499.61 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | EGFR |
| Application: | Cancer-Kinase/protease |
|---|